Apr 26, 2022 Cellectar Biosciences Announces Positive DMC Review of Pivotal Trial of Iopofosine in Waldenstrom’s Macroglobulinemia Learn More
Mar 21, 2022 Cellectar Reports Financial Results for Year Ended December 2021 and Provides a Corporate Update Learn More